Jennison Associates
CABA icon

Jennison Associates’s Cabaletta Bio CABA Stock Holding History

Jennison Associates’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.3M Buy
20,033,730
+11,063,152
+123% +$36.4M 0.04% 209
2026
Q1 		$24.1M Buy
8,970,578
+64,879
+0.7% +$180K 0.02% 309
2025
Q4 		$19.5M Buy
8,905,699
+408,162
+5% +$1.01M 0.01% 343
2025
Q3 		$19.9M Buy
8,497,537
+2,477,370
+41% +$4.25M 0.01% 329
2025
Q2 		$9.15M Buy
6,020,167
+3,586,439
+147% +$5.59M 0.01% 378
2025
Q1 		$3.37M Sell
2,433,728
-78,325
-3% -$167K ﹤0.01% 419
2024
Q4 		$5.7M Sell
2,512,053
-3,120,628
-55% -$11M ﹤0.01% 417
2024
Q3 		$26.6M Buy
5,632,681
+86,214
+2% +$499K 0.02% 316
2024
Q2 		$41.5M Buy
5,546,467
+2,123,483
+62% +$26M 0.03% 240
2024
Q1 		$58.4M Buy
3,422,984
+1,796,356
+110% +$38.6M 0.04% 190
2023
Q4 		$36.9M Buy
1,626,628
+204,261
+14% +$3.43M 0.03% 242
2023
Q3 		$21.6M Buy
1,422,367
+241,803
+20% +$3.3M 0.02% 302
2023
Q2 		$15.2M Buy
1,180,564
+400,000
+51% +$4.34M 0.01% 348
2023
Q1 		$6.46M Buy
+780,564
New +$7.31M 0.01% 423

Other funds holding CABA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates's CABA Position: Q2 2026 in Review

Jennison Associates increased its Cabaletta Bio (CABA) stake by 123% in Q2 2026, buying an estimated $36.4M and bringing the position to 20,033,730 shares worth $62.3M. The position accounts for 0.04% of the portfolio, ranked #209.

Jennison Associates first reported a position in CABA in Q1 2023 and has held it in 14 quarters since. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Jennison Associates held 20,033,730 shares of Cabaletta Bio worth $62.3M as of Q2 2026.
  • Jennison Associates bought 11,063,152 Cabaletta Bio shares in Q2 2026, an estimated $36.4M.
  • Cabaletta Bio made up 0.04% of Jennison Associates's portfolio in Q2 2026, its #209 holding.
  • Jennison Associates first reported a position in Cabaletta Bio in Q1 2023 and has held it in 14 quarters since.
  • 86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.